Rickettsioses imported by travellers and migrants to Spain attended in the +Redivi network, 2009-2020.


Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
18 05 2023
Historique:
received: 17 02 2023
revised: 23 03 2023
accepted: 04 04 2023
medline: 22 5 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

Rickettsioses are emerging zoonotic diseases with worldwide prevalence, recognized as a cause of imported fever in travellers and migrants. Our objective is to describe the microbiological, clinical and epidemiological characteristics of imported rickettsioses in travellers and migrants included in a Spanish collaborative network database. This multicentre retrospective observational study was nested in +Redivi, the Cooperative Network for the Study of Infections Imported by Immigrants and Travellers. We asked collaborating centres for microbiological, clinical and epidemiological data on the rickettsiosis cases from the inception of the network in 2009 to December 2020. Fifty-four cases of imported rickettsioses were included; 35 (64.8%) patients were men, and the median age was 37 years (interquartile range 26, 51.2). Only 7.4% of patients were travellers visiting friends and relatives, and 5.6% were migrants. The most frequent travel destination (38.9%) was South Africa, and 90.7% engaged in a high-risk activity. Twenty-seven patients (50.0%) started presenting symptoms after their return to Spain. The most frequent symptoms were febrile syndrome (55.6%) and cutaneous manifestations (27.8%). Most diagnoses (63.0%) were confirmed by serology. Only a few cases (9.3%) required hospitalization. All participants had a full recovery. Clinicians should suspect rickettsial diseases in travellers coming from high-risk areas, especially Southern Africa, who have engaged in activities in rural areas and natural parks. Doxycycline should be considered in the empiric treatment of imported fever of travellers coming from those areas or who have engaged in high-risk activities. There is a need to improve access to molecular diagnosis of rickettsiosis in Spain.

Sections du résumé

BACKGROUND
Rickettsioses are emerging zoonotic diseases with worldwide prevalence, recognized as a cause of imported fever in travellers and migrants. Our objective is to describe the microbiological, clinical and epidemiological characteristics of imported rickettsioses in travellers and migrants included in a Spanish collaborative network database.
METHODS
This multicentre retrospective observational study was nested in +Redivi, the Cooperative Network for the Study of Infections Imported by Immigrants and Travellers. We asked collaborating centres for microbiological, clinical and epidemiological data on the rickettsiosis cases from the inception of the network in 2009 to December 2020.
RESULTS
Fifty-four cases of imported rickettsioses were included; 35 (64.8%) patients were men, and the median age was 37 years (interquartile range 26, 51.2). Only 7.4% of patients were travellers visiting friends and relatives, and 5.6% were migrants. The most frequent travel destination (38.9%) was South Africa, and 90.7% engaged in a high-risk activity. Twenty-seven patients (50.0%) started presenting symptoms after their return to Spain. The most frequent symptoms were febrile syndrome (55.6%) and cutaneous manifestations (27.8%). Most diagnoses (63.0%) were confirmed by serology. Only a few cases (9.3%) required hospitalization. All participants had a full recovery.
CONCLUSIONS
Clinicians should suspect rickettsial diseases in travellers coming from high-risk areas, especially Southern Africa, who have engaged in activities in rural areas and natural parks. Doxycycline should be considered in the empiric treatment of imported fever of travellers coming from those areas or who have engaged in high-risk activities. There is a need to improve access to molecular diagnosis of rickettsiosis in Spain.

Identifiants

pubmed: 37043288
pii: 7116027
doi: 10.1093/jtm/taad050
pii:
doi:

Types de publication

Observational Study Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Organisme : Instituto de Salud Carlos III
Organisme : Juan Rodés
ID : JR18/00022

Informations de copyright

© International Society of Travel Medicine 2023. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jara Llenas-García (J)

Internal Medicine Department, Infectious Diseases Section, Hospital Vega Baja, 03314 Orihuela, Spain.
Foundation for the Promotion of Health and Biomedical Research of the Valencia Region (FISABIO), 46020, Valencia, Spain.
Clinical Medicine Department, Miguel Hernández University, 03202 Elche, Spain.

Ramiro Cañaveral (R)

Infectious Diseases Unit and Internal Medicine Department, Hospital Universitario Virgen de las Nieves de Granada, 18012 Granada, Spain.

Marta Arsuaga (M)

IDIPAZ, National Referral Unit for Imported Tropical Diseases, Tropical and Travel Medicine Unit, High Level Isolation Unit, La Paz-Carlos III University Hospital, 28046 Madrid, Spain.
CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Begoña Monge-Maillo (B)

CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramon y Cajal University Hospital, IRYCIS, 28034 Madrid, Spain.

Inés Oliveira-Souto (I)

CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Vall d'Hebron-Drassanes International Health Unit, Infectious Diseases Department, PROSICS, Hospital Universitario Vall d'Hebron, 08035 Barcelona, Spain.
Infectious Diseases Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona; International Health Programme of the Catalan Institute of Health (PROSICS), 08035 Barcelona, Spain.

Diego Torrús-Tendero (D)

Referral Unit for Imported Diseases and International Health, Infectious Diseases Unit, Hospital General Universitario Dr. Balmis de Alicante-ISABIAL, Parasitology Area, Miguel Hernández University of Elche, 03202 Alicante, Spain.

Azucena Rodríguez Guardado (A)

Internal Medicine Clinical Management Area, Translational Microbiology Group, ISPA, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.

Eva Calabuig (E)

Infectious Diseases Unit, Hospital Universitario y Politécnico La Fe, Health Research Institute IIS-La Fe, University of Valencia, 46009 Valencia, Spain.

Adrián Sánchez-Montalvá (A)

CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Infectious Diseases Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona; International Health Programme of the Catalan Institute of Health (PROSICS), 08035 Barcelona, Spain.

Ángel Domínguez-Castellano (Á)

Infectious Diseases and Microbiology Department, Hospital Universitario Virgen de la Macarena, 41009 Sevilla, Spain.

Fernando de la Calle-Prieto (F)

IDIPAZ, National Referral Unit for Imported Tropical Diseases, Tropical and Travel Medicine Unit, High Level Isolation Unit, La Paz-Carlos III University Hospital, 28046 Madrid, Spain.
CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.

José A Pérez-Molina (JA)

CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramon y Cajal University Hospital, IRYCIS, 28034 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH